Some content of this application is unavailable at the moment.
If this situation persist, please contact us atFeedback&Contact
1. (WO2017066288) TOPICAL FORMULATIONS FOR PREVENTING SKIN INFECTION
Latest bibliographic data on file with the International Bureau    Submit observation

Pub. No.: WO/2017/066288 International Application No.: PCT/US2016/056592
Publication Date: 20.04.2017 International Filing Date: 12.10.2016
IPC:
A61K 36/18 (2006.01) ,A61K 9/00 (2006.01)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
36
Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
18
Magnoliophyta (angiosperms)
A HUMAN NECESSITIES
61
MEDICAL OR VETERINARY SCIENCE; HYGIENE
K
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9
Medicinal preparations characterised by special physical form
Applicants:
PRACTICAL SOLUTION, INC. [US/US]; 6151 Lake Osprey Drive Sarasota, FL 34240, US
Inventors:
WAN, Zhou; US
GLASSEY, Steve; US
MURPHY, Jay; US
XU, Wei; US
Agent:
CHEN, Yahua; US
Priority Data:
62/241,04813.10.2015US
Title (EN) TOPICAL FORMULATIONS FOR PREVENTING SKIN INFECTION
(FR) FORMULATIONS TOPIQUES PERMETTANT DE PRÉVENIR UNE INFECTION CUTANÉE
Abstract:
(EN) A topical formulation comprising a first active agent that is pharmaceutically acceptable salt of a cationic bisbiguanide such as chlorhexidine digluconate (CHG), a secnd active agent which is a cationic quaternary ammonium compound such as cetylpyridinium chloride (CPC), methylisothiazolone, or chloroxylenol, and a propellant; and an aerosol dispenser containing the topical formulation. The topical formulation can be sprayed onto exposed skin to prevent or reduce the risk of skin infection.
(FR) L'invention concerne une formulation topique comprenant un premier prinicpe actif qui est un sel pharmaceutiquement acceptable d'un bisbiguanide cationique tel que du digluconate de chlorhexidine (CHG), un second principe actif qui est un composé d'ammonium quaternaire cationique tel que du chlorure de cétylpyridinium (CPC), de la méthylisothiazolone, ou du chloroxylénol, et un agent propulseur ; et un distributeur d'aérosol contenant la formulation topique. La formulation topique peut être pulvérisée sur une peau exposée pour prévenir ou réduire le risque d'infection cutanée.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW
African Regional Intellectual Property Organization (ARIPO) (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Office (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (EPO) (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG)
Publication Language: English (EN)
Filing Language: English (EN)